Roivant Sciences Ltd.
NASDAQRoivant Sciences heads into a pivotal stretch — earnings due May 29 — with short sellers rebuilding positions, executives selling stock, and options traders the most bullish they've been in months. The most consequential shift in positioning is in short interest. It has climbed to 5.25% of the free float, up from roughly 4.4% at the start of April — a rise of nearly 20% over six…
Snapshot as of 21 May 2026
Roivant Sciences heads into a pivotal stretch — earnings due May 29 — with short sellers rebuilding positions, executives selling stock, and options traders the most bullish they've been in months. The most…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ROIV — free to start on ORTEX.
Sign up for free →Open ROIV on ORTEX